Technologies for long-term delivery of aerosol medications in asthma and chronic
obstructive pulmonary disease have improved over the past 2 decades with advancements …

There are a multitude of formulation factors to consider when developing a solution-based
pressurized metered dose inhaler (pMDI). Evaluation of these variables and their …

Lung cancers are the leading cause of cancer death for both men and women. A series of
PEGylated poly (amidoamine) dendrimer-based doxorubicin (DOX) nanocarriers (G3NH2 …

Metered dose inhalers (MDIs) are complex drug-device combination products widely used to
treat pulmonary disorders. The efficacy, driven by aerosol performance of the products …

Pressurized Metered-dose Inhalers (pMDIs) are complex drug-device combination products
that are widely used to treat lung diseases, and may also be advantageously employed to …

The lungs are considered as one of the fastest portals of entry to the bloodstream and oral
inhalation (OI) has long been accepted as the preferred mode of administration of …

This Dissertation focuses on addressing two of the major challenges in developing
pressurized metered dose inhalers for pulmonary drug/gene delivery to and through the …

Hydrofluoroalkane-philicity: Excipient Screening for Pressurized Metered Dose Inhaler
Formulations Page 1 143 Respiratory Drug Delivery Europe 2017 – da Rocha and Conti …

Lung cancers are leading cause of cancer death for both men and women in the world.
Lungs are also one of the primary organs to which almost all cancer can spread …

Active Pharmaceutical Ingredients (APIs) are frequently prepared for delivery to the lung for
local topical treatment of diseases such as Chronic Obstructive Pulmonary Disease (COPD) …